Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Up 327.2% in July

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a large growth in short interest in July. As of July 31st, there was short interest totaling 263,441 shares, a growth of 327.2% from the July 15th total of 61,662 shares. Based on an average daily trading volume, of 7,539,029 shares, the short-interest ratio is currently 0.0 days. Currently, 28.9% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on AMIX. Zacks Research raised Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings raised shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a report on Tuesday, July 28th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Autonomix Medical presently has an average rating of “Hold” and a consensus price target of $42.00.

Autonomix Medical Trading Down 1.8%

Autonomix Medical stock opened at $9.12 on Wednesday. The stock has a 50-day moving average price of $6.87 and a two-hundred day moving average price of $7.78. Autonomix Medical has a 12 month low of $2.44 and a 12 month high of $32.55. The company has a market capitalization of $8.86 million, a PE ratio of -0.12 and a beta of -1.16.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.